List of Tables
Table 1. Global Icosapent Ethyl Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Icosapent Ethyl Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Icosapent Ethyl Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Icosapent Ethyl Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Icosapent Ethyl Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Icosapent Ethyl Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Icosapent Ethyl Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Icosapent Ethyl Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icosapent Ethyl Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icosapent Ethyl Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Icosapent Ethyl Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Icosapent Ethyl Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Icosapent Ethyl Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Icosapent Ethyl Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Icosapent Ethyl Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Icosapent Ethyl Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Icosapent Ethyl Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Icosapent Ethyl Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Icosapent Ethyl Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Icosapent Ethyl Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Icosapent Ethyl Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Icosapent Ethyl Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Icosapent Ethyl Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Icosapent Ethyl Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Icosapent Ethyl Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Icosapent Ethyl Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Icosapent Ethyl Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Icosapent Ethyl Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Icosapent Ethyl Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Icosapent Ethyl Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Icosapent Ethyl Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Icosapent Ethyl Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Icosapent Ethyl Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Icosapent Ethyl Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Icosapent Ethyl Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Icosapent Ethyl Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Icosapent Ethyl Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Icosapent Ethyl Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Woodward Pharma Company Information
Table 71. Woodward Pharma Description and Business Overview
Table 72. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Woodward Pharma Icosapent Ethyl Drugs Product
Table 74. Woodward Pharma Recent Developments/Updates
Table 75. Amarin Pharmaceuticals Company Information
Table 76. Amarin Pharmaceuticals Description and Business Overview
Table 77. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product
Table 79. Amarin Pharmaceuticals Recent Developments/Updates
Table 80. Apotex Company Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Apotex Icosapent Ethyl Drugs Product
Table 84. Apotex Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Hikma Icosapent Ethyl Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Teva Icosapent Ethyl Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Ascent Pharmaceuticals Company Information
Table 101. Ascent Pharmaceuticals Description and Business Overview
Table 102. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product
Table 104. Ascent Pharmaceuticals Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zydus Icosapent Ethyl Drugs Product
Table 109. Zydus Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Strides Pharma Icosapent Ethyl Drugs Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. PuraCap Pharmaceuticals Company Information
Table 116. PuraCap Pharmaceuticals Description and Business Overview
Table 117. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 119. PuraCap Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sun Pharma Icosapent Ethyl Drugs Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Mankind Pharma Company Information
Table 126. Mankind Pharma Description and Business Overview
Table 127. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Mankind Pharma Icosapent Ethyl Drugs Product
Table 129. Mankind Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Company Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. GLW Pharma Company Information
Table 136. GLW Pharma Description and Business Overview
Table 137. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. GLW Pharma Icosapent Ethyl Drugs Product
Table 139. GLW Pharma Recent Developments/Updates
Table 140. Sichuan Gowell Pharmaceutical Company Information
Table 141. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 142. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product
Table 144. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Qilu Pharmaceutical Icosapent Ethyl Drugs Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Suncadia Medicine Company Information
Table 151. Chengdu Suncadia Medicine Description and Business Overview
Table 152. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product
Table 154. Chengdu Suncadia Medicine Recent Developments/Updates
Table 155. Jiangsu Wangao Pharmaceutical Company Information
Table 156. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 157. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product
Table 159. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 160. Humanwell Puracap Pharmaceuticals Company Information
Table 161. Humanwell Puracap Pharmaceuticals Description and Business Overview
Table 162. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 164. Humanwell Puracap Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Icosapent Ethyl Drugs Distributors List
Table 168. Icosapent Ethyl Drugs Customers List
Table 169. Icosapent Ethyl Drugs Market Trends
Table 170. Icosapent Ethyl Drugs Market Drivers
Table 171. Icosapent Ethyl Drugs Market Challenges
Table 172. Icosapent Ethyl Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Icosapent Ethyl Drugs
Figure 2. Global Icosapent Ethyl Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Icosapent Ethyl Drugs Market Share by Type: 2023 & 2030
Figure 4. Single Drug Product Picture
Figure 5. Combination Drug Product Picture
Figure 6. Global Icosapent Ethyl Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Icosapent Ethyl Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Icosapent Ethyl Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Icosapent Ethyl Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Icosapent Ethyl Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Icosapent Ethyl Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Icosapent Ethyl Drugs Report Years Considered
Figure 16. Icosapent Ethyl Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Icosapent Ethyl Drugs Players: Market Share by Revenue in Icosapent Ethyl Drugs in 2023
Figure 19. Icosapent Ethyl Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Icosapent Ethyl Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Icosapent Ethyl Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Icosapent Ethyl Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Icosapent Ethyl Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Icosapent Ethyl Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Icosapent Ethyl Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Icosapent Ethyl Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Icosapent Ethyl Drugs by Type (2019-2030)
Figure 53. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Icosapent Ethyl Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Icosapent Ethyl Drugs by Application (2019-2030)
Figure 56. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2019-2030)
Figure 57. Icosapent Ethyl Drugs Value Chain
Figure 58. Icosapent Ethyl Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
